Literature DB >> 8909851

Enterocytozoon bieneusi infection and diarrheal disease in patients who were not infected with human immunodeficiency virus: case report and review.

C A Wanke1, P DeGirolami, M Federman.   

Abstract

We describe the identification of the protozoan parasite Enterocytozoon bieneusi in the stool of a patient who was not infected with HIV but who presented with persistent diarrheal disease and severe abdominal complaints. The patient was not infected with HIV but had been noted to have a decreased CD4 cell count since at least 1992 and had had a prior episode of cryptococcal meningitis. The organisms were detected in stool smears with a modified trichrome stain and were identified to the species level by transmission electron microscopy of the stool. The patient responded readily and dramatically to treatment with albendazole, with resolution of symptoms and clearance of the organisms from the stool. Eight or possibly nine other cases of E. bieneusi infection associated with diarrheal disease in individuals who were not infected with HIV were identified in the English-language literature. In two individuals with intact immune function, symptoms were self-limited and diarrheal disease resolved within 2 weeks. The cases summarized herein suggest that E. bieneusi may be more commonly associated with sporadic diarrheal disease than was previously suspected and that the immune system may play a role in the control of this organism within the intestine.

Entities:  

Mesh:

Year:  1996        PMID: 8909851     DOI: 10.1093/clinids/23.4.816

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

Review 1.  The microsporidian polar tube: a highly specialised invasion organelle.

Authors:  Yanji Xu; Louis M Weiss
Journal:  Int J Parasitol       Date:  2005-08       Impact factor: 3.981

2.  One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption.

Authors:  I Accoceberry; M Thellier; A Datry; I Desportes-Livage; S Biligui; M Danis; X Santarelli
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Relevant criteria for detecting microsporidia in stool specimens.

Authors:  G Chioralia; T Trammer; H Kampen; H M Seitz
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 4.  First cases of microsporidiosis in transplant recipients in Spain and review of the literature.

Authors:  A L Galván; A M Martín Sánchez; M A Pérez Valentín; N Henriques-Gil; F Izquierdo; S Fenoy; C del Aguila
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

5.  Diarrhea in the returned traveler.

Authors:  J W Sanders; D R Tribble
Journal:  Curr Gastroenterol Rep       Date:  2001-08

Review 6.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  Unapparent microsporidial infection among immunocompetent humans in the Czech Republic.

Authors:  Bohumil Sak; Daniel Brady; Markéta Pelikánová; Dana Květoňová; Michael Rost; Martin Kostka; Věra Tolarová; Zuzana Hůzová; Martin Kváč
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

8.  Production of monoclonal antibodies directed against the microsporidium Enterocytozoon bieneusi.

Authors:  I Accoceberry; M Thellier; I Desportes-Livage; A Achbarou; S Biligui; M Danis; A Datry
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

9.  Flow cytometric analysis of microsporidia belonging to the genus Encephalitozoon.

Authors:  D M Moss; G P Croppo; S Wallace; G S Visvesvara
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  Transmission and serial propagation of Enterocytozoon bieneusi from humans and Rhesus macaques in gnotobiotic piglets.

Authors:  I Kondova; K Mansfield; M A Buckholt; B Stein; G Widmer; A Carville; A Lackner; S Tzipori
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.